FYB202 is an interleukin inhibitor that can be used in dermatology to treat psoriasis and in gastroenterology to treat chronic inflammatory bowel disease. The biosimilar received marketing ...
Scientific publicationFormycon presents clinical data on ustekinumab biosimilar FYB202 at the ECCO Congress in Berlin 20.02.2025 / 06:30 CET/CESTThe issuer is solely responsible for the content of ...
Entera Bio (ENTX) announced that the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases Scientific Programme Committee ...
The Institute of Chemical Technology, Mumbai, in collaboration with the Mumbai Biocluster, successfully hosted the 5th Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback